z-logo
open-access-imgOpen Access
Fungal sensitization of patients with asthma in St. Petersburg
Author(s) -
Y I Kozlova,
Я И Козлова,
Е. В. Фролова,
Е. В. Фролова,
А В Соболев,
А В Соболев,
О В Аак,
Аак О В,
А Е Учеваткина,
А Е Учеваткина,
Л В Филиппова,
Л В Филиппова,
Ekaterina Burygina,
Ekaterina Burygina,
Н Н Климко,
Н Н Климко
Publication year - 2015
Publication title -
rossijskij allergologičeskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2686-682X
pISSN - 1810-8830
DOI - 10.36691/rja414
Subject(s) - sensitization , asthma , medicine , immunology , aspergillus fumigatus , immunoglobulin e , allergy , alternaria , aspergillus , biology , microbiology and biotechnology , antibody , genetics
Background. Fungal sensitization is associated with severe uncontrolled asthma. Connections of specific, micromycetes and fungal allergens with disease development and immunopathogenesis of asthma with fungal sensitization are not well understood. Methods. The study included 120 patients with different grades of asthma severity. Results. Fungal sensitization was detected in 48 patients with asthma (40%). Severe course of asthma with fungal sensitization was identified in 7 patients (14,6%). The main fungal allergens in patients with severe asthma were Alternaria spp. and Aspergillus spp., in patients with mild and moderate course of disease - Aspergillus spp. and Penicillium spp. Increasing of serum total IgE and enhancing the ability of blood cells to produce IL2 and IFN-y in patients with bronchial asthma with fungal sensitization were revealed. The obtained results indicated the important role of Th1 along with Th2 cells in the development of immunopathological process in asthma patients withfungal sensitization. Conclusion. Further research is necessary for determination of clinical and immunological criteria of severe asthma with fungal sensitization and study of the effectiveness of antimycotic therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here